BackSagimet Biosciences Overview

Sagimet Biosciences Current Cash

Sagimet Biosciences's current cash is $170M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$165.90M
↑ 291.94% YoYΔ $123.57M vs prior year quarter

Peer trimmed avg / median

Loading

Sagimet Biosciences Current Cash History

Loading

Sagimet Biosciences vs. peers: Current Cash Comparison

Loading

Sagimet Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sagimet Biosciences (SGMT) FAQ

Sagimet Biosciences (SGMT) currently reports a current cash of $170M as of June 2026. That compares with $42M in the prior-year period — up 291.9% year over year. Use the charts on this page to explore Sagimet Biosciences's current cash history and peer comparisons.

Sagimet Biosciences's current cash increased from $42M to $170M — a 291.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sagimet Biosciences reported $170M in current cash as of June 2026. That compares with $42M in the prior-year period — up 291.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sagimet Biosciences, and consider following SGMT for alerts when major investors trade the stock.